Humacyte FDA Accepts IND for First-in-Human CTEV CABG Study
DURHAM, N.C., July 27, 2026 Humacyte, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its...
coronary artery disease
Advertisement
4DMedical Unlocks Advanced CT:VQ Imaging for Australia
MELBOURNE, Australia, June 29, 2026 4DMedical has achieved a major regulatory milestone with the Therapeutic Goods Administration (TGA) approving...
Terumo Completes First U.S. OPUSWAVE Imaging Procedure
SOMERSET, N.J., June 29, 2026 Terumo Interventional Systems (TIS), a division of Terumo Corporation, has announced the successful completion...
Artivion Brings FDA-Approved AMDS to U.S. Heart Centers
ATLANTA, Ga., June 29, 2026 Artivion, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted...
Endeavor Health Unveils Advanced Genetic Test for Heart Disease
EVANSTON, Ill., June 2, 2026 Researchers at Endeavor Health have developed a groundbreaking genetic screening tool designed to provide...
Advertisements
Lilly’s VERVE-102 Shows Durable LDL-C Reduction
Indianapolis, Indiana, USA, May 25, 2026 Eli Lilly and Company has announced positive Phase 1b clinical results for VERVE-102,...
Tempus Launches AI Prostate Test for Advanced Cancer
Chicago, Illinois, USA – May 21, 2026 Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced...
Bayer Gains FDA Priority Review for Kerendia
WHIPPANY, N.J., May 21, 2026 Bayer has announced that the U.S. Food and Drug Administration (FDA) has granted Priority...
Reflow Medical Reports Positive Six-Month Spur Elute Coronary Study Results
SAN CLEMENTE, Calif., May 20, 2026 Reflow Medical, Inc. has announced encouraging six-month clinical results from its DEEPER CORONARY...
Abbott Ultreon 3.0 AI Imaging Gains FDA, CE Approval
ABBOTT PARK, Illinois, USA, April 28, 2026 Abbott has announced that its next-generation Ultreon™ 3.0 AI-powered coronary imaging platform...
Advertisement
